Association Between Disease-Free Survival and Overall Survival When Survival Is Prolonged After Recurrence in Patients Receiving Cytotoxic Adjuvant Therapy for Colon Cancer: Simulations Based on the 20,800 Patient ACCENT Data Set

PURPOSE: We previously validated disease-free survival (DFS) as a surrogate for overall survival (OS) in fluorouracil-based adjuvant colon cancer clinical trials. New therapies have extended survival after recurrence from 1 to approximately 2 years. We examined the possible impact of this improvemen...

Πλήρης περιγραφή

Αποθηκεύτηκε σε:
Λεπτομέρειες βιβλιογραφικής εγγραφής
Κύριοι συγγραφείς: de Gramont, Aimery, Hubbard, Joleen, Shi, Qian, O'Connell, Michael J., Buyse, Marc, Benedetti, Jacqueline, Bot, Brian, O'Callaghan, Chris, Yothers, Greg, Goldberg, Richard M., Blanke, Charles D., Benson, Al, Deng, Qiqi, Alberts, Steven R., Andre, Thierry, Wolmark, Norman, Grothey, Axel, Sargent, Daniel
Μορφή: Artigo
Γλώσσα:Inglês
Έκδοση: American Society of Clinical Oncology 2010
Θέματα:
Original Reports
Διαθέσιμο Online:https://ncbi.nlm.nih.gov/pmc/articles/PMC2815708/
https://ncbi.nlm.nih.gov/pubmed/20008641
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2009.23.1407
Ετικέτες: Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!

Παρόμοια τεκμήρια